自動微生物学装置のアメリカ市場

Venture Planning Groupが発行した調査報告書(DATA70609087)
◆英語タイトル:US Automated Microbiology Market 2021: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening and Immunodiagnostic Tests, Technology and Instrumentation Review
◆商品コード:DATA70609087
◆発行会社(リサーチ会社):Venture Planning Group
◆発行日:2017年6月
◆ページ数:436
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:米国
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Local PDFUSD9,850 ⇒換算¥1,113,050見積依頼/購入/質問フォーム
Global PDFUSD21,700 ⇒換算¥2,452,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はVenture Planning Group社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Venture Planning Group社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Complete report $9,850.  DataPack (test volumes, sales forecasts, supplier shares) $6,400.

VPGMarketResearch.com’s new report is an analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the U.S. automated microbiology market; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for molecular diagnostic, microbial identification, antibiotic susceptibility, blood culture, urine screening and immunodiagnostic procedures, as well as over 100 infectious disease tests by assay, application, market segment, profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The level of automation in the microbiology laboratory has been lagging behind that of other major clinical laboratory segments, such as chemistry and hematology. The slow acceptance of the technology is in part due to the complexity of developing automation suitable for microbiology tests.

The introduction of automated microbiology instrumentation has been delayed by a number of intrinsic and technical problems. The diffusion of automated microbiology systems, once the technology was developed, has not matched that of other automated laboratory technologies. The acquisition of automation in microbiology has been slowed by forces less easily identifiable than the effects of various reimbursement plans. Some laboratorians still believe that current instrumentation is not the ultimate technology and expect better automation on the horizon.

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expense are coming under severe scrutiny worldwide.

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology market, in evaluating emerging opportunities and developing effective business strategies.

Supplier Shares, Sales and Volume Forecasts

- Sales and market shares of major suppliers of microbiology products, by individual test.

- Five-year test volume and sales forecasts for over 100 microbiology assays.

- Test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy).

U.S. Market Overview

- Review of the market dynamics, trends, structure, size, growth and major suppliers.

- Estimated universe of laboratories performing microbiology testing.

- Specimen, test volume and sales forecasts.

Business Opportunities and Strategic Recommendations

- Emerging opportunities for new analyzers, reagents kits, IT and other products with significant market appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Specimen Types

- Urine
- Sterile Fluids: Blood, Serum, CSF
- Throat Swabs, Respiratory Secretions
- Genital Secretions
- Stool
- Abscess/Wound
- Sputum
- Saliva

Applications

- Microbial Identification
- Antibiotic Susceptibility
- Urine Screening
- Blood Cultures

Review of Major Automated Systems

- Review of major automated molecular diagnostic, multipurpose, specialized, microbial identification, antibiotic susceptibility, blood culture, urine screening, and immunodiagnostic analyzers.

- The report features analyzers manufactured by Abbott, Alifax, Anagen, BD, Beckman Coulter/Danaher, Biochem, Biolog, bioMerieux, Bio-Rad, Biotrol, Cepheid, Curetis, GenMark, Hologic/Gen-Probe, HTG, Iris, J&J, Labsystems, Life Technologies, MiDI, Olympus, Qiagen, Roche, Siemens, Sy-Lab, Sysmex, Tecan, Thermo Fisher, Tosoh.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease, Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia and others.

Technology Assessment

- Assessment of molecular diagnostic, monoclonal antibody, immunoassay, and other technologies and their potential applications for the microbiology market.

- Global listings of companies developing or marketing microbiology products by individual test.

Competitive Strategies

- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

- The companies analyzed in the report include:

  – Abbott
  – Affymetrix
  – Agilent Technologies
  – Applied Gene Technologies
  – Arca Biopharma
  – Beckman Coulter/Danaher
  – Becton Dickinson
  – Biokit
  – bioMerieux
  – Bio-Rad
  – Biotest
  – CellMark Forensics/LabCorp
  – Cepheid
  – Decode Genetics
  – Diadexus
  – Diamedix
  – DiaSorin
  – Eiken Chemical
  – Elitech Group
  – Enzo Biochem
  – Exact Sciences
  – Fujirebio
  – Grifols
  – Hologic/Gen-Probe
  – ID Biomedical/GSK
  – Illumina
  – Kreatech/Leica
  – Li-Cor Biosciences
  – Lonza
  – Monogram Biosciences
  – Myriad Genetics
  – Ortho-Clinical Diagnostics
  – Perkin Elmer/Caliper Life Sciences
  – Proteome Sciences
  – Qiagen
  – Roche
  – Scienion
  – Sequenom
  – SeraCare
  – Shimadzu
  – Siemens
  – Sierra Molecular
  – Takara Bio
  – Tecan
  – Thermo Fisher
  – Wallac/PE
  – Wako

Contains 436 pages and 94 tables

【レポートの目次】

http://www.vpgcorp.com/webfiles/MICROBIOLOGY/TOCLOTNewFrontiersintheUSAutomatedMicrobiologyMarketBusinessChallengesEmergingTechCompetitiveLandscape.pdf

http://www.vpgmarketresearch.com/pdffiles/LOTUSAutomatedMicrobiologyMarket.pdf

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 自動微生物学装置のアメリカ市場(US Automated Microbiology Market 2021: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening and Immunodiagnostic Tests, Technology and Instrumentation Review)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆